Regeneron
Trade Regeneron 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About REGN
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara.
REGN Key Statistics
Stock Snapshot
With a market cap of 77.27B, Regeneron(REGN) trades at $747.37. The stock has a price-to-earnings ratio of 18.59 and currently yields dividends of 0.49%.
As of 2026-09-30, Regeneron(REGN) stock has fluctuated between $747.37 and $747.37. The current price stands at $747.37, placing the stock 0.0% above today's low and 0.0% off the high.
Regeneron(REGN) shares are trading with a volume of 99, against a daily average of 873.41K.
In the last year, Regeneron(REGN) shares hit a 52-week high of $859.34 and a 52-week low of $541.00.
In the last year, Regeneron(REGN) shares hit a 52-week high of $859.34 and a 52-week low of $541.00.
REGN News
...
Kodiak Sciences reported Phase 3 data showing Zenkuda matched Regeneron Pharmaceuticals (NasdaqGS:REGN) eye drug Eylea in macular degeneration. The trial used...
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Regeneron (REGN Quick QuoteREGN - Free Report) and Illumina (ILM...
Analyst ratings
60%
of 30 ratingsMore REGN News
A federal judge has dismissed a securities fraud lawsuit against Regeneron Pharmaceuticals (REGN) and several of its executives, with the court directing the Cl...
Shares of Kodiak Sciences surged more than 170% Monday—on pace for its largest one-day increase on record—after the company announced its eye drug matched Regen...
Key Points Regeneron's stock has underperformed the market this year, but it got a boost last time it reported earnings. The company's revenue grew by 17% las...
Citi says shares of Regeneron (REGN) are down after Kodiak Sciences’ (KOD) Zenkuda delivered non-inferior vision gains versus aflibercept in a Phase 3 wet age-r...
Regeneron Pharmaceuticals Inc.’s (NASDAQ:REGN) stock is trading lower on Monday, probably in reaction to positive data from Kodiak Sciences Inc.’s (NASDAQ:KOD)...
Kodiak Sciences Inc. (NASDAQ:KOD) on Monday released data from the Phase 3 DAYBREAK trial for patients suffering from wet age-related macular degeneration (wAMD...
Oil Shipper Hits New High; Three Stocks Also Near Pivots 8/21/2026 Oil transportation stock Frontline is at a new high in Friday's stock market. Advantest, Reg...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.